Lapatinib induces downregulation of matrix metallopeptidase 1 and deactivation of ERK1/2 and PI3K pathway in endometrial cancer

被引：1
|
作者：
Lai, C. [1 ,2 ]
Lin, C. [1 ]
Chao, A. [1 ,2 ]
Hsueh, S. [1 ]
Wang, T. [1 ,2 ]
机构：
[1] Chang Gung Mem Hosp, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.336
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
335
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [31] MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway
    Hassan, Ghmkin
    Afify, Said M.
    Du, Juan
    Nawara, Hend M.
    Sheta, Mona
    Monzur, Sadia
    Zahra, Maram H.
    Abu Quora, Hagar A.
    Mansour, Hager
    El-Ghlban, Samah
    Uesaki, Ryo
    Seno, Akimasa
    Seno, Masaharu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 583 : 49 - 55
  • [32] Osteopontin Induces Epithelial-to-Mesenchymal Transitions in Human Lung Cancer Cells via PI3K/Akt and MEK/Erk1/2 Signaling Pathways
    Shi, Lin
    Wang, Lin
    Wang, Xiang
    CHEST, 2016, 149 (04) : 332A - 332A
  • [33] Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway
    Miyake, M.
    Goodison, S.
    Lawton, A.
    Gomes-Giacoia, E.
    Rosser, C. J.
    ONCOGENE, 2015, 34 (07) : 890 - 901
  • [34] Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation
    Yi Liu
    Liqun Lv
    Wei Xiao
    Cheng Gong
    Jie Yin
    Donghua Wang
    Hui Sheng
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31
  • [35] Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells
    Conde, Isabel
    Pabon, Dina
    Jayo, Asier
    Lastres, Pedro
    Gonzalez-Manchon, Consuelo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (05) : 430 - 440
  • [36] Leptin Activates STAT3 and ERK1/2 Pathways and Induces Endometrial Cancer Cell Proliferation
    Liu, Yi
    Lv, Liqun
    Xiao, Wei
    Gong, Cheng
    Yin, Jie
    Wang, Donghua
    Sheng, Hui
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2011, 31 (03) : 365 - 370
  • [37] Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways
    Hu, Yuan
    Jing, Jiayu
    Shi, Yu
    Zhang, Pengchuang
    Dong, Danfeng
    Wu, Yinying
    Dong, Xuyuan
    Li, Enxiao
    Fan, Yangwei
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (07) : 3306 - 3316
  • [38] Dual inhibition of PI3K and Erk1/2 shows synergy and efficacy in human tumor cells, either by using drug combinations or novel dual PI3K/Erk inhibitors
    Seipelt, Irene
    Gerlach, Matthias
    Blumenstein, Lars
    Mueller, Gilbert
    Guenther, Eckhard
    Engel, Juergen
    Teifel, Michael
    CANCER RESEARCH, 2012, 72
  • [39] 1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one induces lung cancer cell apoptosis via the PI3K/Akt and ERK1/2 pathways
    Fan, Jiangjiang
    Wu, Mingsheng
    Wang, Jian
    Ren, Dongmei
    Zhao, Jian
    Yang, Guotao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 6336 - 6349
  • [40] Recombinant tissue plasminogen activator induces neutrophil degranulation activating PI3K/Akt- and ERK1/2-mediated pathways
    Bertolotto, M.
    Carbone, F.
    Vuilleumier, N.
    Burger, F.
    Dallegri, F.
    Pende, A.
    Artom, N.
    Mach, F.
    Fainardi, E.
    Montecucco, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 : 60 - 60
12345